DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Wang D, Fu B, Peng Z. et al.
Tocilizumab ameliorates the hypoxia in COVID-19 moderate patients with bilateral
pulmonary lesions: A randomized, controlled, open-label, multicenter trial.
SSRN 2020;
DOI: 10.2139/ssrn.3667681.
We do not assume any responsibility for the contents of the web pages of other providers.